Knowledge · DoNotAge.org
DoNotAge.org Supplement Through To XPRIZE Final
First published:
A team of researchers using DoNotAge.org SIRT6Activator® to try and reverse aging are finalists in a competition to win tens of millions of dollars in funding.
The XPRIZE Healthspan launched in 2023 with a challenge to the longevity field: prove your intervention works in humans. This week it named the 20 finalists who will attempt to do this.
The Competition
Between now and 2029, each team will run a trial in adults aged 50-90. The goal is to restore muscle, brain, and immune function lost to at least ten years of aging. Teams that successfully show this level of age reversal in humans will win research funding of up to $82 million.
One of the 20 finalists is the NUS Academy for Healthy Longevity in Singapore, whose approach to the anti-aging challenge includes SIRT6Activator®.
We don’t have anything to do with their attempt, process, or planning outside of providing the ingredients. The scientists know which ingredients are the best, that’s why they choose DoNotAge.org
They’ve got one chance to win a life-changing amount of funding and make history in the process, and they chose SIRT6Activator® to help them achieve that.
We want to congratulate the NUS team for getting this far and wish them the best of luck for the rest of the competition!
One of the best things about this is, whether they win or not, SIRT6Activator® is about to be put through yet another independent, controlled test in older adults. We will keep a close eye on their progress and share any updates with you immediately.
From what we know about SIRT6Activator® and the huge benefits it’s given our community members, we think the NUS team has a great shot at the prize!
